Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03303716 · ClinicalTrials.gov registry record
ASXL-Related Disorders Natural History Study
A clinical trial of Bainbridge-Ropers Syndrome and Bohring-Opitz Syndrome, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT03303716: Recruiting study of Bainbridge-Ropers Syndrome and Bohring-Opitz Syndrome, sponsored by University of California, Los Angeles.
NCT03303716 is a study of Bainbridge-Ropers Syndrome and Bohring-Opitz Syndrome that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03303716, a study of Bainbridge-Ropers Syndrome and Bohring-Opitz Syndrome, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).
Primary Outcome
Use participant surveys including the GRDR CDE standard questions to collect data on disease history and management. Attain primary medical records with goal of publications to enhance treatment, management and understanding of the natural history of ASXL gene disorders.
Conditions Studied
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2037-09 |
What NCT03303716 shows while recruiting
NCT03303716 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 6 conditions, with Bainbridge-Ropers Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT03303716 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03303716 about?
NCT03303716 is a clinical study titled "ASXL-Related Disorders Natural History Study". A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).
What is the current status of trial NCT03303716?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2017-09-20. Estimated completion is 2037-09.
What conditions does trial NCT03303716 study?
This clinical trial studies the following conditions: Bainbridge-Ropers Syndrome, Bohring-Opitz Syndrome, ASXL1 Gene Mutation, Shashi-Pena Syndrome, ASXL2 Gene Mutation.
Who is sponsoring clinical trial NCT03303716?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03303716 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bainbridge-Ropers Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI